These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30076944)

  • 1. Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors.
    Islam M; Saltzman AF; Amini A; Carrasco A; Cost NG
    Urology; 2018 Oct; 120():222-230. PubMed ID: 30076944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Care and Survival Comparison of Adult and Pediatric Wilms Tumor in the United States: A Study of the National Cancer Database.
    Saltzman AF; Carrasco A; Amini A; Cost NG
    Urology; 2020 Jan; 135():50-56. PubMed ID: 31669270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators.
    Zhuge Y; Cheung MC; Yang R; Perez EA; Koniaris LG; Sola JE
    J Surg Res; 2010 Oct; 163(2):257-63. PubMed ID: 20538287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.
    Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y;
    Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical tactics in the treatment of malignant renal tumors in childhood.
    Pýcha K; Snajdauf J; Koutecký J; Kodet R; Zítková M
    Pediatr Surg Int; 1997 Feb; 12(2-3):145-7. PubMed ID: 9156843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant renal tumors in childhood: report of 54 cases treated at a single institution.
    Jaing TH; Hung IJ; Yang CP; Lai JY; Tseng CK; Chang TY; Hsueh C; Tsay PK
    Pediatr Neonatol; 2014 Jun; 55(3):175-80. PubMed ID: 24279977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
    Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
    Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
    Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
    Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.
    Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA
    Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathology of uncommon malignant renal neoplasms in the pediatric age group.
    Radhika S; Bakshi A; Rajwanshi A; Nijhawan R; Das A; Kakkar N; Joshi K; Marwaha RK; Rao KL
    Diagn Cytopathol; 2005 May; 32(5):281-6. PubMed ID: 15830360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 20-year prospective study of Wilms tumor and other kidney tumors: a report from Hong Kong pediatric hematology and oncology study group.
    Chan CC; To KF; Yuen HL; Shing Chiang AK; Ling SC; Li CH; Cheuk DK; Li CK; Shing MM
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):445-50. PubMed ID: 25050908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.
    Cai W; Liu X; Ge W; Wu D; Xu J; Bai R; Hu H
    Int J Med Sci; 2021; 18(4):911-920. PubMed ID: 33456348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.